Cebiotex raises a € 1.8 million in second funding round Blog Post

Cebiotex –a spin-off of the Hospital Sant Joan de Déu in Barcelona (HSJD) and the Universitat Politècnica de Catalunya (UPC) based at the Barcelona Science Park (PCB)– has closed a funding round totaling € 1.8 million. that will allow the company to complete the regulatory pre-clinical phase of post-surgery cancer treatment for soft tissue sarcomas CEB-01. This is the first therapeutic indication developed by its innovative technology platform Cebiotex®, based on biomedical application of nanofibers for the local delivery of drugs (Local Drug Delivery System).

 

The V International Academic Symposium of IEB analyses the challenges of energy economics Blog Post

Yesterday, February 7, the V International Symposium of the Barcelona Institute of Economics (IEB) of the UB on the challenges in the energy sector took place at he Barcelona Science Park. The previous day, the Foundation for Energy and Environmental Sustainability (Funseam), which analyzes and shares the results of the research of the Chair of Energy Sustainability of the UB, had also organized its V International Symposium at PCB with the participation from public officers and businesspeople from the main firms of this sector. 

 

Researchers find a new key target for the treatment of prostate cancer Blog Post

A team led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) –at the Barcelona Science Park– and the Research Institute of the Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau) shows for the first time, the three-dimensional structure of the homodimeric androgen receptor ligand-binding domain, a structure that eluded researchers for years. This new structure of the nuclear receptor allows explaining more than forty mutations related to prostate cancer, one of the most common worldwide and especially in Catalonia, as well as known developing disorders.

 

Esteve and SEFAC come together to implement a therapeutic adherence plan in community pharmacies Blog Post

Esteve and the Spanish Society of Community Pharmacy (SEFAC) have signed an agreement whereby both entities will collaborate in the development of a program of activities to foster and implement a treatment adherence plan in community pharmacies over the next two years. With this alliance, Esteve –which has its Center for Drug Discovery and Preclinical Development at PCB – reaffirms its commitment to provide answers to medical needs not covered properly.

 

Salvador Aznar Benitah receives the VI National ‘Doctores Diz Pintado’ Cancer Research Prize Blog Post

ICREA researcher and group leader of the Stem Cells and Cancer Laboratory at IRB Barcelona, Salvador Aznar Benitah, has been awarded the VI National ‘Doctores Diz Pintado’ Cancer Research Prize. Last Saturday, he received the award during the academic session held by the University of Salamanca. The prize acknowledges Salvador Aznar Benitah’s contributions to transferring knowledge from basic to clinical research.

 

First 3D observation of nanomachines working inside cells Blog Post

Today scientists at the Institute for Research in Biomedicine (IRB Barcelona) at the Barcelona Science Park present a study in Cell where they have been able to observe protein nanomachines (also called protein complexes)—the structures responsible for performing cell functions—for the first time in living cells and in 3D. This work has been done in collaboration with researchers at the University of Geneva in Switzerland and the Centro Andaluz de Biología del Desarrollo in Seville.

 

A public-private project to treat atherosclerosis led by Iproteos receives € 700,000 Blog Post

A public-private consortium led by the biotech  Iproteos – based at the Barcelona Science Park (PCB)– with the participation of the Biomedical Research Institute of Barcelona (IIBB) belonging to the Spanish National Research Council (CSIC) and the Centre for Genomic Regulation (CRG), has launched a project to validate a new family of compounds for the treatment of cholesterol vascular accumulation associated with atherosclerosis. The project has just received  a grant for 700,000 Euros from the Ministry of Economy, Industry and Competitiveness, through the 2016 Retos-Colaboración call under the scope of the National Programme for Research Aimed at the Challenges of Society (Exp. RTC-2016-5078-1).